carnosol and Non-alcoholic-Fatty-Liver-Disease

carnosol has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies

Other Studies

1 other study(ies) available for carnosol and Non-alcoholic-Fatty-Liver-Disease

Article	Year
Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3. Toxicology and applied pharmacology, 2021, 12-01, Volume: 432 Mitochondrial dysfunction is a major factor in nonalcoholic fatty liver disease (NAFLD), preceding insulin resistance and hepatic steatosis. Carnosol (CAR) is a kind of diterpenoid with antioxidant, anti-inflammatory and antitumor activities. Peroxiredoxin 3 (PRDX3), a mitochondrial H Topics: Abietanes; Animals; Antioxidants; Apoptosis; Cell Line; Diet, High-Fat; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Hepatocytes; Liver; Male; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Dynamics; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Peroxiredoxin III	2021

Article

Year

Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3.

Toxicology and applied pharmacology, 2021, 12-01, Volume: 432

Mitochondrial dysfunction is a major factor in nonalcoholic fatty liver disease (NAFLD), preceding insulin resistance and hepatic steatosis. Carnosol (CAR) is a kind of diterpenoid with antioxidant, anti-inflammatory and antitumor activities. Peroxiredoxin 3 (PRDX3), a mitochondrial H

Topics: Abietanes; Animals; Antioxidants; Apoptosis; Cell Line; Diet, High-Fat; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Hepatocytes; Liver; Male; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Dynamics; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Peroxiredoxin III

2021